摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(2-hydroxy-ethyl)-4-methyl-3-(2-methyl-6-oxo-1,6-dihydro-pyrimidin-5-ylmethyl)-thiazolium; [4-(4-dimethylamino-phenylazo)-benzenesulfonate ] | 123965-06-0

中文名称
——
中文别名
——
英文名称
5-(2-hydroxy-ethyl)-4-methyl-3-(2-methyl-6-oxo-1,6-dihydro-pyrimidin-5-ylmethyl)-thiazolium; [4-(4-dimethylamino-phenylazo)-benzenesulfonate ]
英文别名
5-(2-Hydroxy-aethyl)-4-methyl-3-(2-methyl-6-oxo-1,6-dihydro-pyrimidin-5-ylmethyl)-thiazolium; [4-(4-Dimethylamino-phenylazo)-benzolsulfonat]
5-(2-hydroxy-ethyl)-4-methyl-3-(2-methyl-6-oxo-1,6-dihydro-pyrimidin-5-ylmethyl)-thiazolium; [4-(4-dimethylamino-phenylazo)-benzenesulfonate ]化学式
CAS
123965-06-0
化学式
C12H16N3O2S*C14H14N3O3S
mdl
——
分子量
570.693
InChiKey
WGGCUEXGZKFMCJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.39
  • 重原子数:
    39.0
  • 可旋转键数:
    8.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    155.02
  • 氢给体数:
    2.0
  • 氢受体数:
    10.0

反应信息

  • 作为反应物:
    描述:
    5-(2-hydroxy-ethyl)-4-methyl-3-(2-methyl-6-oxo-1,6-dihydro-pyrimidin-5-ylmethyl)-thiazolium; [4-(4-dimethylamino-phenylazo)-benzenesulfonate ] 、 alkaline earth salt of/the/ methylsulfuric acid 、 alkaline earth salt of/the/ methylsulfuric acid 生成 N-[(Z)-3-[[(Z)-2-[formyl-[(2-methyl-6-oxo-1H-pyrimidin-5-yl)methyl]amino]-5-hydroxypent-2-en-3-yl]disulfanyl]-5-hydroxypent-2-en-2-yl]-N-[(2-methyl-6-oxo-1H-pyrimidin-5-yl)methyl]formamide
    参考文献:
    名称:
    铁氰化钾氧化硫胺素及其类似物
    摘要:
    DOI:
    10.1039/jr9540004585
  • 作为产物:
    参考文献:
    名称:
    Use of Muscle Functional Magnetic Resonance Imaging With Older Individuals
    摘要:
    Muscle functional magnetic resonance imaging (mfMRI) has been widely used to study muscle recruitment in exercise in young healthy subjects, but has not been validated or used with older subjects. This study validates and demonstrates the use of mfMRI in older subjects. Subjects consisted of apparently healthy sedentary younger (n = 7) and older (n = 6) women. Proton transverse relaxation (T2)-weighted MRI scans were obtained of the quadriceps femoris at rest and immediately following three bouts of knee extension exercise (50%, 75%, and 100% of untrained 5 x 10 repetition maximum [RM]). Older subjects performed knee extension training for 12 weeks and repeated the MRI scan protocol using the same absolute loads. Training induced a 13% increase in 1 RM and a 25% increase in 5 x 10 RM. Older subjects had higher resting T2 values compared with younger subjects; however, the T2 response to exercise (slope) was similar among groups (young = 0.063 +/- 0.003, older untrained = 0.055 +/- 0.011, older trained = 0.053 +/- 0.008; p > .05). In all cases, T2 increased Linearly with load. Trained older subjects showed a lower T2 response when lifting the same absolute load compared with before training, which is consistent with results previously obtained from young subjects. In the older population, mfMRI is appropriate for use and offers benefits over other technologies.
    DOI:
    10.1093/gerona/55.10.b504
点击查看最新优质反应信息

文献信息

  • Does Age Change the Distribution of Visual Attention? A Comment on McCalley, Bouwhuis, and Juola (1995)
    作者:F. W. Cornelissen、A. C. Kooijman
    DOI:10.1093/geronb/55.3.p187
    日期:2000.5.1
    A paper, by McCalley, Bouwhuis, and Juola (1995) suggested differences between younger and older adults in the use of visual cues. Furthermore, they reported these differences could largely be attributed to diminished (peripheral al) visual proressing capacities of elderly adults. I-It re, we reanalyze the data of McCalley and colleagues emphasizing relative rather than absolute differences. We find that when doing so, the data do not reveal differences in the way older and younger adults transiently allocate attention during visual search. Contrary to the conclusions of McCalley and colleagues, the similarity between the younger and older observers is therefore independent of the characteristics of the visual information. Furthermore, in our view the data suggest that older adults have foveal rather than peripheral visual processing difficulties. The results reemphasize the importance of the analytical approach taken in aging research, We discuss the difficulties and relevance of controlling and separating visual and attentional factors in age-related studies.
  • Matsukawa; Yurugi, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1951, vol. 71, p. 827
    作者:Matsukawa、Yurugi
    DOI:——
    日期:——
  • 310. Aneurin. Part VIII. Some analogues of aneurin
    作者:F. Bergel、A. R. Todd
    DOI:10.1039/jr9370001504
    日期:——
  • Note on an improved method for the preparation of oxythiamine
    作者:H. N. Rydon
    DOI:10.1042/bj0480383
    日期:1951.3.1
  • Studies on Oxythiamine
    作者:Morris Soodak、Leopold R. Cerecedo
    DOI:10.1021/ja01239a510
    日期:1944.11
查看更多

同类化合物

黑洞猝灭剂-2,BHQ-2ACID 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S,24S)- 颜料橙61 阿利新黄GXS 阳离子红X-GTL 阳离子红5BL 阳离子橙RN 阳离子橙GLH 间甲基红 镨(3+)丙烯酰酸酯 镍酸酯(1-),[3-羟基-4-[(4-甲基-3-硫代苯基)偶氮]-2-萘羧酸根(3-)]-,氢 锂3-({4-[(4-羟基苯基)偶氮]-5-甲氧基-2-甲基苯基}偶氮)苯磺酸酯 钴,[二[m-[[1,2-二苯基-1,2-乙二酮1,2-二(肟酸根-kO)](2-)]]四氟二硼酸根(2-)-kN1,kN1',k2,kN2']-,(SP-4-1)- 钠5-氯-2-羟基-3-[(2-羟基-4-{[(4-甲基苯基)磺酰基]氧基}苯基)偶氮]苯磺酸酯 钠5-[[3-[[5-[[4-[[[4-[(4,5-二氢-3-甲基-5-氧代-1H-吡唑-4-基)偶氮]苯基]氨基]羰基]苯基]偶氮]-2,4-二羟基苯基]偶氮]-4-羟基苯基]偶氮]水杨酸盐 钠4-[(4-氨基苯基)偶氮]苯甲酸酯 钠4-[(4-{[4-(二乙基氨基)苯基]偶氮}苯基)偶氮]苯磺酸酯 钠4-[(4-{[2-羟基-5-(2-甲基-2-丙基)苯基]偶氮}苯基)偶氮]苯磺酸酯 钠4-({3-甲氧基-4-[(4-甲氧基苯基)偶氮]苯基}偶氮)苯磺酸酯 钠3-[4-(2-羟基-5-甲基-苯基)偶氮苯基]偶氮苯磺酸酯 钠3-({5-甲氧基-4-[(4-甲氧基苯基)偶氮]-2-甲基苯基}偶氮)苯磺酸酯 钠3-({4-[(4-羟基-2-甲基苯基)偶氮]-3-甲氧基苯基}偶氮)苯磺酸酯 金莲橙O 重氮基烯,苯基[4-(三氟甲基)苯基]- 重氮基烯,二[4-(1-甲基乙基)苯基]-,(Z)- 重氮基烯,二[4-(1-甲基乙基)苯基]-,(E)- 重氮基烯,[4-[(2-乙基己基)氧代]-2,5-二甲基苯基](4-硝基苯基)- 重氮基烯,1,2-二(4-丙氧基苯基)-,(1E)- 重氮基烯,(2-氯苯基)苯基- 酸性金黄G 酸性棕S-BL 酸性媒染棕 酸性媒介棕6 酸性媒介棕48 酸性媒介棕4 酸性媒介棕24 邻氨基偶氮甲苯 达布氨乙基甲硫基磺酸盐 赛甲氧星 茴香酸盐己基 茜素黄 R 钠盐 苯重氮化,2-甲氧基-5-甲基-4-[(4-甲基-2-硝基苯基)偶氮]-,氯化 苯酰胺,4-[4-(2,3-二氢-1,4-苯并二噁英-6-基)-5-(2-吡啶基)-1H-咪唑-2-基]- 苯酚,4-(1,1-二甲基乙基)-2-(苯偶氮基)- 苯酚,2-甲氧基-4-[(4-硝基苯基)偶氮]- 苯胺棕 苯胺,4-[(4-氯-2-硝基苯基)偶氮]- 苯磺酸,3,3-6-(4-吗啉基)-1,3,5-三嗪-2,4-二基二亚氨基2-(乙酰基氨基)-4,1-亚苯基偶氮二-,盐二钠 苯磺酸,2-[(4-氨基-2-羟基苯基)偶氮]- 苯甲酸,5-[[4-[(乙酰基氨基)磺酰]苯基]偶氮]-2-[[3-(三氟甲基)苯基]氨基]-(9CI)